The effect of cisplatin dose administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

被引：2
|
作者：
Loong, H. H. F.
Ma, B.
Mo, F.
Leung, S. F.
Hui, E. P.
Kam, M. K.
Chan, S. L.
Chan, A. T. C.
机构：
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Clin Oncol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China
[4] CUHK, Sir YK Pao Ctr Canc, Hong Kong Canc Inst, Shatin, Hong Kong, Peoples R China
[5] CUHK, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5532
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
    Zhang, Jianyuan
    Chen, Shaojun
    Li, Guisheng
    Zhang, Weihua
    Qin, Tingting
    Yin, Ping
    Huang, Haixin
    Jiang, Hongwei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1087 - 1097
  • [32] Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
    Jianyuan Zhang
    Shaojun Chen
    Guisheng Li
    Weihua Zhang
    Tingting Qin
    Ping Yin
    Haixin Huang
    Hongwei Jiang
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1087 - 1097
  • [33] Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index
    Durankus, Nulifer Kilic
    Somay, Efsun
    Bascil, Sibel
    Senyurek, Sukran
    Ozturk, Duriye
    Selek, Ugur
    Topkan, Erkan
    BIOMOLECULES AND BIOMEDICINE, 2024, 25 (01): : 240 - 248
  • [34] Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity
    Xu, Jianhua
    He, Xia
    Cheng, Kong
    Guo, Wenjie
    Bian, Xiuhua
    Jiang, Xuesong
    Zhang, Lanfang
    Huang, Shengfu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (10): : 1474 - 1480
  • [35] Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Wang, Fangzheng
    Jiang, Chuner
    Ye, Zhimin
    Sun, Quanquan
    Liu, Tongxin
    Xu, Min
    Wu, Peng
    Shi, Kaiyuan
    Long, Bin
    Rihito, Aizawa
    Masoto, Sakamoto
    Fu, Zhenfu
    ONCOTARGET, 2017, 8 (43) : 75544 - 75556
  • [36] Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma A Randomized Clinical Trial
    Miao, Jingjing
    Wang, Lin
    Tan, Sze Huey
    Li, Jin-Gao
    Yi, Junlin
    Ong, Enya H. W.
    Tan, Laura L. Y.
    Zhang, Ye
    Gong, Xiaochang
    Chen, Qiuyan
    Xiang, Yan-Qun
    Chen, Ming-Yuan
    Guo, Ying
    Lv, Xing
    Xia, Wei-Xiong
    Tang, Linquan
    Deng, Xiaowu
    Guo, Xiang
    Han, Fei
    Mai, Hai-Qiang
    Chua, Melvin L. K.
    Zhao, Chong
    JAMA ONCOLOGY, 2022, 8 (12) : 1776 - 1785
  • [37] Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Treatment outcomes of a prospective, multicentric clinical study
    Wu, Fang
    Wang, Rensheng
    Lu, Heming
    Wei, Bo
    Feng, Guosheng
    Li, Guisheng
    Liu, Meilian
    Yan, Haolin
    Zhu, Jinxian
    Zhang, Yong
    Hu, Kai
    RADIOTHERAPY AND ONCOLOGY, 2014, 112 (01) : 106 - 111
  • [38] Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
    Zhang, Yuan
    Sun, Ying
    Ma, Jun
    CANCER COMMUNICATIONS, 2019, 39
  • [39] Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study
    Chen, Qiuyan
    Tang, Linquan
    Liu, Na
    Han, Feng
    Guo, Ling
    Guo, Shanshan
    Wang, Jianwei
    Liu, Huai
    Ye, Yanfang
    Zhang, Lu
    Liu, Liting
    Wang, Pan
    Li, Yingqin
    He, Qingmei
    Yang, Xiaoqun
    Tang, Qingnan
    Li, Yang
    Liang, YuJing
    Sun, XueSong
    Xie, Chuanmiao
    Mo, Yunxian
    Guo, Ying
    Sun, Rui
    Mo, Haoyuan
    Cao, Kajia
    Guo, Xiang
    Zeng, Musheng
    Mai, Haiqiang
    Ma, Jun
    CANCER COMMUNICATIONS, 2018, 38
  • [40] The safety and efficacy of gemcitabine and cisplatin (GP)‐based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta‐analysis
    Min Tang
    Zhongxiong Jia
    Ju Zhang
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 1561 - 1572
12345